MAPT and Cognitive impairment: Also, changes in CSF Aβ42 and P-Tau may appear ahead of the symptoms of cognitive impairment on patients, and the above-mentioned changes in CSF biomarkers may also exist in patients with MCI (Sperling et al., 2011).